Is it safe to use lower blood counts (haemoglobin levels) as a trigger for blood transfusion in order to give fewer blood transfusions?
Blood transfusions are a very common medical procedure, and it ’s important to balance the potential benefits and harms. In December 2021, Jeffrey Carson from Rutgers Robert Wood Johnson Medical School, in New Brunswick in the USA, and colleagues updated the Cochrane Review of research comparing different triggers for transfusing red blood cells and we asked him to tell us more about the importance of the review and its findings. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - January 31, 2022 Category: General Medicine Authors: Cochrane Source Type: podcasts
Exercise Training for HFpEF, Blood Transfusion for AMI and Anemia, Review of Hip and Knee OA, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the February 9, 2021 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - February 9, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Oral iron chelating agents: improving quality of life in transfusion-dependent thalassemia
Transfusion-dependent thalassemia demands regular and time-consuming treatment, with patients requiring blood transfusions every few weeks, and for the iron that accumulates as a result of these trans...
Author: VJHemOnc
Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts
Does using daratumumab make response-monitoring difficult?
In this weeks video, Dr. Brian Durie explains how daratumumab may interfere with response-monitoring and with blood transfusions for myeloma patients.<br /><br />BOTTOM LINE: <br />If you are taking dara, discus...
Author: InternationalMyelomaFoundation
Added: 06/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 20, 2017 Category: Cancer & Oncology Source Type: podcasts
Is it safe to use lower blood counts as a trigger for blood transfusion in order to give fewer blood transfusions?
Blood transfusions are a very common medical procedure, and it ’s important to balance the potential benefits and harms. In October 2016, Jeffery Carson from Rutgers Robert Wood Johnson Medical School, in New Brunswick in the USA, and colleagues updated the Cochrane Review of research comparing different triggers for transfusing red blood cells and we asked h im to tell us more about the importance of the review and its findings. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - November 21, 2016 Category: Journals (General) Authors: Cochrane Source Type: podcasts
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis
Anaemia is very common among patients with moderate or severe chronic kidney disease; and several treatments are available including iron supplementation, blood transfusions and synthetic derivatives of erythropoietin. In a Cochrane Review published in December 2014, Suetonia Palmer from Christchurch in New Zealand together with her colleagues, brought together the studies that have tested a range of erythropoietin drugs and she tells us what they found in this Evidence Pod. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - July 8, 2015 Category: Journals (General) Authors: Cochrane Source Type: podcasts
Too much blood: when transfusions do more harm than good
Blood transfusions have been identified as one of the most overused therapies both in the United States and the UK.
In this podcast Lawrence Tim Goodnough, from Stanford University Medical Center's Transfusion Service, and Michael Murphy, from NHS Blood and Transplant, explain the physiological reasons why
liberal blood transfusion will not... (Source: The BMJ Podcast)
Source: The BMJ Podcast - December 5, 2014 Category: Journals (General) Authors: BMJ talk medicine Source Type: podcasts
Too much blood: when transfusions do more harm than good
Blood transfusions have been identified as one of the most overused therapies both in the United States and the UK.
In this podcast Lawrence Tim Goodnough, from Stanford University Medical Center's Transfusion Service, and Michael Murphy, from NHS Blood and Transplant, explain the physiological reasons why
liberal blood transfusion will not benefit patients, and can potentially harm them.
Read their full analysis:
http://www.bmj.com/content/349/bmj.g6897 (Source: The BMJ Podcast)
Source: The BMJ Podcast - December 5, 2014 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Billy Heddins, Liver Cancer Survivor
, shares his inspiring and touching journey through liver cancer. He discusses learning that he had Hepatitis C from a long past blood transfusion, discovering that...
Author: SayYEStoHOPE
Added: 10/01/2014 (Source: Oncology Tube)
Source: Oncology Tube - October 1, 2014 Category: Cancer & Oncology Source Type: podcasts
Kidney Cancer News - February 2014
Blood transfusion may affect survival.
Author: kidneycancer
Added: 07/22/2014 (Source: Oncology Tube)
Source: Oncology Tube - July 22, 2014 Category: Cancer & Oncology Source Type: podcasts
Lost in transfusion?
Blood transfusion is an essential part of modern healthcare and can be lifesaving when used appropriately. In this podcast, Sophie Cook, The BMJ's clinical reviews editor, talks to Michael Murphy, consultant haematologist and professor of blood transfusion medicine at NHS Blood and Transplant at the John Radcliffe Hospital, Oxford, about best... (Source: The BMJ Podcast)
Source: The BMJ Podcast - August 5, 2013 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Lost in transfusion?
Blood transfusion is an essential part of modern healthcare and can be lifesaving when used appropriately. In this podcast, Sophie Cook, The BMJ's clinical reviews editor, talks to Michael Murphy, consultant haematologist and professor of blood transfusion medicine at NHS Blood and Transplant at the John Radcliffe Hospital, Oxford, about best practice for the safety of patients receiving blood; including ways to reduce unnecessary transfusion, and the warning signs of an adverse reaction. (Source: The BMJ Podcast)
Source: The BMJ Podcast - August 5, 2013 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Hereditary Spherocytosis: A Patient's Journey
Ezra, age 6, suffers from a rare hereditary disease, spherocytosis, which leads to severe anemia. When Ezra was born, his parents were told he had less than two weeks to live, and blood transfusions ...
Author: ash
Added: 05/10/2011 (Source: Oncology Tube)
Source: Oncology Tube - May 10, 2011 Category: Cancer & Oncology Source Type: podcasts
Hereditary Spherocytosis: A Patient's Journey
Ezra, age 6, suffers from a rare hereditary disease, spherocytosis, which leads to severe anemia. When Ezra was born, his parents were told he had less than two weeks to live, and blood transfusions ...
Author: ash
Added: 05/10/2011 (Source: Oncology Tube)
Source: Oncology Tube - May 10, 2011 Category: Cancer & Oncology Source Type: podcasts
